Matches in SemOpenAlex for { <https://semopenalex.org/work/W51150746> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- W51150746 endingPage "3" @default.
- W51150746 startingPage "2800" @default.
- W51150746 abstract "Natural interferon-alpha preparation Sumiferon was recently developed in Japan. This is a human lymphoblastoid interferon (HLBI) preparation. Like other interferon preparations, this preparation showed both direct and indirect antitumor effect and the toxicities were moderate. The phase I-II studies were carried out in 38 major institutions in Japan. In the phase I study in 5 patients with advanced breast cancer, the maximum tolerated dose (MTD) was found to be 12 X 10(6) units/day given for 1 month. In the phase II study, HLBI was given in at 3 approximately 6 X 10(6) units/day. Out of 391 cases, 280 were evaluable. Complete and partial responses (CR and PR) were observed in 40 (14.3%) out of 280 evaluable cases, including 11 (19.6%) out of 56 renal cell cancer, 14 (19.2%) out of 73 multiple myeloma, and 9 (17.3) out of 52 malignant lymphoma among others. Major side effects observed were: fever (69.8%), gastrointestinal disturbances (31.4%), leukopenia (30.7%), thrombocytopenia (27.8%), hepatotoxicities (23.6%) and general fatigue (22.1%). Sumiferon seemed to be one of useful antitumor drugs effective against renal cancer." @default.
- W51150746 created "2016-06-24" @default.
- W51150746 creator A5033562835 @default.
- W51150746 date "1987-09-01" @default.
- W51150746 modified "2023-09-23" @default.
- W51150746 title "[Introduction of natural interferon-alpha Sumiferon]." @default.
- W51150746 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3631977" @default.
- W51150746 hasPublicationYear "1987" @default.
- W51150746 type Work @default.
- W51150746 sameAs 51150746 @default.
- W51150746 citedByCount "0" @default.
- W51150746 crossrefType "journal-article" @default.
- W51150746 hasAuthorship W51150746A5033562835 @default.
- W51150746 hasConcept C121608353 @default.
- W51150746 hasConcept C126322002 @default.
- W51150746 hasConcept C203014093 @default.
- W51150746 hasConcept C2776178377 @default.
- W51150746 hasConcept C2776364478 @default.
- W51150746 hasConcept C2776694085 @default.
- W51150746 hasConcept C2779338263 @default.
- W51150746 hasConcept C2780873365 @default.
- W51150746 hasConcept C2909179924 @default.
- W51150746 hasConcept C71924100 @default.
- W51150746 hasConcept C90924648 @default.
- W51150746 hasConceptScore W51150746C121608353 @default.
- W51150746 hasConceptScore W51150746C126322002 @default.
- W51150746 hasConceptScore W51150746C203014093 @default.
- W51150746 hasConceptScore W51150746C2776178377 @default.
- W51150746 hasConceptScore W51150746C2776364478 @default.
- W51150746 hasConceptScore W51150746C2776694085 @default.
- W51150746 hasConceptScore W51150746C2779338263 @default.
- W51150746 hasConceptScore W51150746C2780873365 @default.
- W51150746 hasConceptScore W51150746C2909179924 @default.
- W51150746 hasConceptScore W51150746C71924100 @default.
- W51150746 hasConceptScore W51150746C90924648 @default.
- W51150746 hasIssue "9" @default.
- W51150746 hasLocation W511507461 @default.
- W51150746 hasOpenAccess W51150746 @default.
- W51150746 hasPrimaryLocation W511507461 @default.
- W51150746 hasRelatedWork W123319480 @default.
- W51150746 hasRelatedWork W158907189 @default.
- W51150746 hasRelatedWork W1595172314 @default.
- W51150746 hasRelatedWork W1996352524 @default.
- W51150746 hasRelatedWork W2033584229 @default.
- W51150746 hasRelatedWork W2045572710 @default.
- W51150746 hasRelatedWork W2396514826 @default.
- W51150746 hasRelatedWork W2468074350 @default.
- W51150746 hasRelatedWork W4230126353 @default.
- W51150746 hasRelatedWork W3022065830 @default.
- W51150746 hasVolume "14" @default.
- W51150746 isParatext "false" @default.
- W51150746 isRetracted "false" @default.
- W51150746 magId "51150746" @default.
- W51150746 workType "article" @default.